Aerogen Pharma Enters into Exclusive Agreements with Nuance Pharma to Advance Treatment of Respiratory Distress Syndrome in Premature Infants in China
SHANGHAI, Dec. 23, 2021 /PRNewswire/ -- Aerogen Pharma, a developer of innovative inhaled treatments for patients in critical care, and Nuance Pharma ("Nuance"), a specialty care focused biopharma with late-stage clinical programs and existing commercial operations, today announce an exclusive agreement to join forces in Greater China to develop a superior, non-invasive approach to treatment of RDS, a life-threatening...
LINEPHARMA INTERNATIONAL FILES FOR MANUFACTURING, MARKETING APPROVAL OF THE ABORTION PILL IN JAPAN
LONDON and TOKYO, Dec. 23, 2021 /PRNewswire/ -- Linepharma International Ltd., a global leader in medical abortion, announced today that its subsidiary Linepharma KK has applied for manufacturing and marketing approval in Japan for its oral drug MEFEEGO™ for the medical termination of pregnancies of up to 63 days of gestation. The medication is recognized as the international gold standard for...
Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent Studies
- Two-dose primary regimen of NVX-CoV2373 demonstrated cross-reactive immune responses against Omicron (B.1.1.529) and other variants - Third dose produced increased immune responses comparable to or exceeding levels associated with protection in Phase 3 clinical trials, with a 9.3-fold IgG rise and a 19.9-fold ACE2 inhibition increase after booster dose -...
Origin Agritech Developing Nutrition Enhanced Corn Using CRISPR Gene Editing
BEIJING, Dec. 23, 2021 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology company, announced today that it is developing nutritionally enhanced corn using CRISPR technology. Origin is currently in trials to develop new corn varieties that have been genetically engineered to have balanced amino acid content. If these trials are successfully completed, it...
Steri-Tech Chooses CleanAir Engineering’s Picarro-Based Ethylene Oxide Solution for Multi-Point Indoor Air Quality Monitoring at Commercial Sterilization Facility
Combination of Advanced Technology and Turn-Key Solutions Will Enable Accurate Ethylene Oxide Emissions Quantification and Aid in Promoting a Safer Sterilization Process SANTA CLARA, Calif. and PALATINE, Ill., Dec. 22, 2021 /PRNewswire/ -- Steri-Tech, Inc. (Steri-Tech), a Puerto Rican corporation founded in 1986 that specializes in contract sterilization of medical devices with ethylene oxide EtO including validation services, has...
Deargen Annonuces Patent Application for a TNBC Target Novel Drug Candidate Using AI
Using a self-developed AI platform, it takes only 10 weeks from the discovery of the anticancer drug targets to the discovery and synthesis of new compounds. Proven capabilities for NCE compound discovery and design, and the establishment of a R&D center(iDear Center) to continuously develop patented substances. SEOUL, South Korea, Dec. 22, 2021 /PRNewswire/ --...
AMO Pharma Announces Expansion of Pivotal REACH-CDM Study in Congenital Myotonic Dystrophy
- Additional research centers now enrolling patients in Australia and New Zealand - Company has achieved 50 percent of target enrollment in global Phase 3 trial LONDON, Dec. 23, 2021 /PRNewswire/ -- AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare childhood-onset neurogenetic disorders with limited or no treatment options, today announced the completion...
Angel Yeast Invests in New Enzyme Project Capable of 5,000 Tons Annual Production Output
YICHANG, China, Dec. 22, 2021 /PRNewswire/ -- Angel Enzyme Preparation (Yichang) Co., Ltd., ("Angel Enzyme Preparation"), a wholly-owned subsidiary of Angel Yeast Co., Ltd., is well underway with construction on its new green manufacturing project in Angel Biotechnology Industrial Park, Xiaoting District, Yichang City, which commenced in September 2021. Once complete, the project...
People-focused Highbrook Medical Centre is Now Officially Open
AUCKLAND, New Zealand, Dec. 22, 2021 /PRNewswire/ -- Highbrook Medical Centre, the newest of Health Improvement Group's Auckland clinics, including Botany Junction and Ormiston Medical, is now officially open and accepting new patient enrolments. Despite the lockdown, Highbrook Medical Centre opened under Level 4 rules. The clinic works with employers in Highbrook Business Park and greater East Tamaki commercial areas...
Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines
US Patent and Trademark Office has granted Exopharm patent US 11202805, for its LEAP™ exosome purification technology. LEAP™ enables large-scale, clinical grade commercial production of exosomes needed to underpin the emerging field of exosome medicines. Exopharm is seeking potential partners and licensees, with LEAP™ having the potential to become the industry standard for exosome production, as...
